I agree that this site is using cookies. You can find further informations here.
X
Astermark, J.
256  results:
Search for persons X
?
1

OC 59.3 Pooled Safety Results from the Multidose Explorer S..:

Eichler, H. ; Matsushita, T. ; Angchaisuksiri, P....
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 100433 , 2023
Link: https://doi.org/10.1016/..
 
?
2

OC 52.3 Efficacy and Safety of Fidanacogene Elaparvovec in ..:

Cuker, A. ; Alzahrani, H. ; Astermark, J....
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 100452 , 2023
Link: https://doi.org/10.1016/..
 
?
3

PB0186 Results from BeneGene-1 Study: Prospective Collectio..:

Matino, D. ; Alzahrani, H. ; Cuker, A....
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 101217 , 2023
Link: https://doi.org/10.1016/..
 
?
4

European principles of inhibitor management in patients wit..:

Hermans, C. ; Giangrande, P. L. F. ; O'Mahony, B....
Orphanet Journal of Rare Diseases.  15 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
5

The role of the laboratory in diagnosis and management of i..:

Strandberg, K. ; Astermark, J.
Haemophilia.  24 (2018)  S6 - p. 9-14 , 2018
Link: https://doi.org/10.1111/..
 
?
6

The association between health utility and joint status amo..:

Osooli, M. ; Steen Carlsson, K. ; Baghaei, F....
Haemophilia.  23 (2017)  3 - p. , 2017
Link: https://doi.org/10.1111/..
 
?
7

Surgery and survival in birth cohorts with severe haemophil..:

Osooli, M. ; Steen Carlsson, K. ; Astermark, J..
Haemophilia.  23 (2017)  5 - p. , 2017
Link: https://doi.org/10.1111/..
 
?
8

Discrepancies between the one‐stage clotting assay and the ..:

Kihlberg, K. ; Strandberg, K. ; Rosén, S...
Haemophilia.  23 (2017)  4 - p. 620-627 , 2017
Link: https://doi.org/10.1111/..
 
?
9

Intensity of factorVIIItreatment and the development of inh..:

Velzen, A. S. ; Eckhardt, C. L. ; Peters, M....
Journal of Thrombosis and Haemostasis.  15 (2017)  7 - p. 1422-1429 , 2017
Link: https://doi.org/10.1111/..
 
?
10

Comparative burden of arthropathy in mild haemophilia: a re..:

Osooli, M. ; Lövdahl, S. ; Steen Carlsson, K....
Haemophilia.  23 (2017)  2 - p. , 2017
Link: https://doi.org/10.1111/..
 
?
11

Current view and outcome of ITI therapy - A change over tim..:

Holstein, K. ; Batorova, A. ; Carvalho, M....
Thrombosis Research.  148 (2016)  - p. 38-44 , 2016
Link: https://doi.org/10.1016/..
 
?
12

HEALTH UTILITIES IN INHIBITOR NEGATIVE PATIENTS WITH HEMOPH..:

Osooli, M. ; Steen Carlsson, K. ; Baghaei, F....
Value in Health.  19 (2016)  3 - p. A251 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Anti‐factor VIII antibodies in brothers with haemophilia A ..:

Kahle, J. ; Orlowski, A. ; Stichel, D....
Haemophilia.  23 (2016)  2 - p. 292-299 , 2016
Link: https://doi.org/10.1111/..
 
?
14

Inhibitor development and mortality in non‐severe hemophili..:

Eckhardt, C.L. ; Loomans, J.I. ; van Velzen, A.S....
Journal of Thrombosis and Haemostasis.  13 (2015)  7 - p. 1217-1225 , 2015
Link: https://doi.org/10.1111/..
 
?
15

A comparison of the treatment of patients with factor IX de..:

Berntorp, E. ; Shapiro, A. D. ; Waters, J..
Haemophilia.  20 (2014)  5 - p. , 2014
Link: https://doi.org/10.1111/..
 
1-15